The Characteristics and Clinical Outcome of Drug-induced Liver Injury:A Single-center Experience

Journal of Clinical Gastroenterology

Volumn 44, Issue 6, 2010, Pages e128-e132

  Idilman, Ramazan ^a   Bektas, Mehmet ^a   Cnar, Kubilay ^a   Toruner, Murat ^b   Cerit, Ethem Turgay ^b   Doganay, Beyza ^b   Erden, Esra ^b   Bozkaya, Hakan ^b   Bahar, Kadir ^c   Karayalcin, Selim ^c   Soykan, Irfan ^c   Palabiyikoglu, Murat ^c   Cetinkaya, Hulya ^c   Yurdaydin, Cihan ^c   Dokmeci, Abdulkadir ^c   Ozden, Ali ^c  

^a Institute of Gastroenterology   (Turkey)

^b Internal Medicine   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Acute liver failure; Drug induced liver injury; Hepatotoxicity; Toxic hepatitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON; MACROLIDE; METRONIDAZOLE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORNIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TUBERCULOSTATIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; JAUNDICE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TOXIC HEPATITIS; ACUTE DISEASE; DRUG-INDUCED LIVER INJURY; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; TURKEY; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TURKEY;

EID: 77953741231     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181c5e9cc     Document Type: Article

References (24)

1. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349:474-485.
2. Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol. 2005;33:155-164.
3. Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007;11:459-475.
4. Norris W, Angelo H, Paredes AH, et al. Drug-induced liver injury in 2007. Curr Opin Gastroenterol. 2008;24:287-297.
5. Takikawa H. Recent status of drug-induced liver injury. Hepatol Res. 2009;39:1-6.
6. Ostapowicz G, Fontana RJ, Schiodt FV, et al. US Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.
7. Kaplowitz N. Drug metabolism and hepatotoxicity. In: Kaplowitz N, ed. Liver and Biliary Diseases. 2nd ed. Baltimore, MD: Williams and Wilkins; 1996:103-120.
8. Zimmerman H. Drug-induced liver disease. In: Schiff E, Sorrell M, Madrey W, eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia, PA: Lippincott-Raven; 1999:973-1064.
9. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451-455.
10. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period. Gastroenterology. 2005;129:512-521.
11. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11:272-276.
12. Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology. 2006;43:618-631.
13. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439-445.
14. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135:1924-1934.
15. Björnsson E, Kalaitzakis E, Av Klinteberg V, et al. Long-term follow-up of patients with mild to moderate drug-induced liver injury. Aliment Pharmacol Ther. 2007;26:79-85.
16. Polson JE. Hepatotoxicity due to antibiotics. Clin Liver Dis. 2007;11:549-561.
17. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis. 2002;22:145-155.
18. Gresser U. Amoxicillin-clavulinic acid therapy may be associated with severe side effects: review of the literature. Eur J Med Res. 2001;6:139-149.
19. Westphal JF, Brogard JM. Antibacterial and antifungal agents. In: Kaplowitz N, DeLeve L, eds. Drug Induced Liver Disease. New York: Marcel Dekker; 2003:471-504.
20. Ganey PE, Luyendyk JP, Maddox JF, et al. Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact. 2004;150:35-51.
21. Russo MW, Galanko JA, Shresta R, et al. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023.
22. Kilic M, Aydin U, Noyan A, et al. Live donor liver transplantation for acute liver failure. Transplantation. 2007;84:475-479.
23. Bleibel W, Kim S, D'Silva K, et al. Drug-induced liver injury: review article. Dig Dis Sci. 2007;52:2463-2471.
24. Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut. 1999;44:731-735.